On June 20, 2017, DevicePharm was represented with a featured group of business leaders in the “Women’s Executive Network Leadership Conference” sponsored by AdvaMed. The event, held in Boston, included an amazing group of medical device leaders. The attendance, which set a new event record, included participants ranging from large medical device organizations to emerging tech companies.
Toronto-based 7D Surgical launched the first MvIGS (Machine-vision Image Guided Surgery) platform at the 2017 AANS neurosurgery meeting in Los Angeles. The campaign, “The IGS Promise. Delivered.” resonated with hundreds of surgeons participating in interactive demonstrations throughout the conference.
On June 6, 2017, DevicePharm was honored to make the opening presentation at the 2017 Spring BioBash in Austin, Texas. The presentation was titled, “So You’re Going To Launch”. It was presented to provide a guide for med-tech executives, marketers, and entrepreneurs who are launching new products, companies, and markets.
On May 18, 2017, DevicePharm and Medical Alley Association co-sponsored an event titled “Communicating Value – Marketing Success In A Value-Driven Environment”. The event, held in the iconic Guthrie Theater in downtown Minneapolis, was attended by 200 members of the Minnesota medical device, biotech, diagnostics, and pharmaceutical community.
On May 1, 2017, DevicePharm announced the opening of our new office in Austin, Texas. This office was developed to serve the growing medical technology industry in Austin, Houston, Dallas, and San Antonio.
Clay Wilemon, DevicePharm CEO and Chief Strategy Officer described the motivation for opening the Austin office, “Texas has over 700 medical device, biotech, diagnostics, and pharmaceutical companies.
On February 22, 2017, Sonex Health announced the successful completion of the first ultrasound-guided carpal tunnel release procedure in the United States using the SX-One MicroKnife™. The SX-One MicroKnife™ is an ultra-low profile surgical device that allows physicians to perform Micro-invasive carpal tunnel release (CTR) surgery through a single micro-incision (4-5 mm) using ultrasound guidance.
The scenario is common. A new medical technology is introduced that potentially improves care and practice economics, but also disrupts conventional care patterns. The question in these scenarios is, “How do we quantify the clinical and economic value and how do we communicate that to clinicians?”
7D Surgical announced today that it has received both 510(k) clearance from the U.S. Food and Drug Administration (FDA) and a medical device license from Health Canada enabling the North American commercial launch of its innovative Machine-vision Image Guided Surgery (MIGS™) system for spine surgery, the 7D Surgical System. This breakthrough system is designed to simplify and speed up surgical workflow, increase surgeon control, eliminate intraoperative radiation, and deliver exceptional value.
DevicePharm is pleased to announce Amber Chao’s promotion to Vice President, Group Account Director at DevicePharm. Amber has lead teams that have helped DevicePharm clients successfully launch dozens of market-leading and innovative brands around the globe. She has earned the respect of both clients and colleagues.
DevicePharm, a marketing strategy and integrated marketing solutions firm, was awarded two 2016 International Davey Awards this month for work created on behalf of Bausch + Lomb’s VICTUS® Femtosecond Laser Platform brand and Clarity Medical’s HOLOS IntraOp™ brand.